Immuntherapie:Offener Zugang

Immuntherapie:Offener Zugang
Offener Zugang

ISSN: 2471-9552

Volumen 3, Ausgabe 1 (2017)

Forschungsartikel

Joint Action of the Nano-sized System of Small Non-coding RNAs with DDMC Vector and Recombinant IL-7 Reprograms A-549 Lung Adenocarcinoma Cells into CD4+ Cells

Oxana V. Klimenko*

Teile diesen Artikel

Rezensionsartikel

Overview of the Soluble and Membrane-bound Tumor Factors Limiting NK-mediated Immune Surveillance

Cristina Bottino, Mariella Della Chiesa, Alessandra Dondero*, Francesca Bellora, Beatrice Casu, Alessandro Moretta and Roberta Castriconi

Teile diesen Artikel

Forschungsartikel

Aviscumine (ME-503)-Skin Reaction as significant Factor for its Efficacy Expanded Evaluation of the Results from the Phase II Trial NCT00658437 in Patients with Unresectable stage IV Metastatic Melanoma

Uwe Trefzer, Ralf Gutzmer, Tabea Wilhelm, Florian Schenck, Katharina C. Kähler, Volkmar Jacobi, Klaus Witthohn, Hans Lentzen* and Peter Mohr

Teile diesen Artikel

Rezensionsartikel

The Excellent Antitumor Effect of IL-24 and the Complete Eradication of the Xenograft Tumor with CTGVT-DG Strategy

Xin-Yuan Liu*,Kang-Jian Zhang,Jin-Fa Gu, Xian-Long Fangi, Ai-min Ni,Sheng-Fei He and Qi Kang

Teile diesen Artikel
Top